Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2513-2524
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2513
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2513
Pathological N staging | N staging of three-phase dynamic contrast-enhanced CT | Expression of CD34-marked MVD | ||||
N0 | N1 | N2 | N3 | Accuracy | ||
N0 (n = 37) | 28 | 6 | 3 | 0 | 75.68 | 52.43 ± 12.77 |
N1 (n = 27) | 3 | 20 | 4 | 0 | 74.07 | 71.89 ± 10.13 |
N2 (n = 20) | 0 | 1 | 17 | 2 | 85.00 | 86.83 ± 9.74 |
N3 (n = 22) | 0 | 2 | 3 | 17 | 77.27 | 102.07 ± 11.27 |
- Citation: Liu H, Zhao KY. Application of CD34 expression combined with three-phase dynamic contrast-enhanced computed tomography scanning in preoperative staging of gastric cancer. World J Gastrointest Surg 2023; 15(11): 2513-2524
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2513.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2513